J&J Accepts $4B Carlyle Offer For Blood-Testing Unit
New Jersey-based Johnson & Johnson said on Monday that it has accepted private equity giant The Carlyle Group's $4 billion buyout offer for its blood-testing diagnostics unit, Ortho-Clinical Diagnostics Inc., squeezing...To view the full article, register now.
Already a subscriber? Click here to view full article